Adult survivors of Hodgkin lymphoma had nearly twice the mortality of the general United States population, according to a population-based retrospective cohort study of 20,057 long-term survivors. Read more: https://www.emjreviews.com/en-us/amj/hematology/news/hodgkin-lymphoma-survivors-face-higher-long-term-mortality/

Now, mounting evidence, including findings from three prospective clinical trials, reveal that nontransplant options are an effective...

Replacing brentuximab vedotin with nivolumab in first-line treatment combined with the chemotherapy regimen AVD improved progression-free...

Hypothyroidism and hypogonadism are likely among cranial radiotherapy-treated survivors of childhood-onset acute lymphoblastic leukemia...

The research also found that women treated for Hodgkin lymphoma may have to try for longer to become pregnant; however, the majority of ...

Children with high-risk Hodgkin lymphoma were 10% less likely to relapse following treatment with brentuximab vedotin combination. Read...

Patients with early-stage classic Hodgkin lymphoma and other neoplasms exhibited higher risk for cardiovascular disease-associated...

"Despite receiving no neurotoxic therapy directed to the central nervous system, long-term survivors of childhood Hodgkin lymphoma (HL)...

New research refines existing evidence that survivors of childhood Hodgkin lymphoma face an elevated risk of developing various types of...

Cardiovascular toxicities occurred more frequently and severely among adult survivors of pediatric, adolescent and young adult Hodgkin...